Recombinant CD19 (Inebilizumab Biosimilar) 抗体
The Mammalian Cells 单克隆 anti-CD19 (Inebilizumab Biosimilar) antibody (ABIN7488071) specifically detects CD19 (Inebilizumab Biosimilar) in ELISA.
The antibody is reactive with 人 samples.
产品编号 ABIN7488071
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CD19 (Inebilizumab Biosimilar) 抗体 (ABIN7488071)
抗原
CD19 (Inebilizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This CD19 (Inebilizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Inebilizumab Biosimilar - Anti-CD19 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD19 (Inebilizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MEDI-551
Inebilizumab is a humanized afucosylated monoclonal IgG1 antibody that targets the broadly expressed B-cell surface antigen CD19. Inebilizumab is cytolytic, which may be usefull to treat neuromyelitis optica spectrum disorder (NMOSD)through B-cell depletion. -
CAS-编号
- 1299440-37-1
抗原
-
You are here:
